This medication is a monoclonal antibody, prescribed for HER2-positive breast cancer (which is more aggressive) either alone or with other medications. It stops cancer cell growth.
IV- The recommended initial dose is 840 mg, followed every 3 weeks thereafter by a dose of 420 mg.
It comes as a solution for injection to be administered by a healthcare provider into the vein.
• Caution should be exercised in patients with liver or kidney impairment, during pregnancy and breastfeeding.
• Patient may develop with increased risk of ventricular dysfunction; monitor heart function regularly while taking this medication.
• It may cause harm to fetus when it is administered to pregnant women; consult with your healthcare provider before taking this medication.
• Most Common :
Diarrhea, hair loss, decrease in white blood cells, stomach upset, fatigue, rash, damage to the nerves.
• General : Fatigue, weakness, swelling in the extremities, fever.
• Skin: Hair loss, nail disorder, itching, dry skin.
• Gastrointestinal : Nausea, vomiting, constipation, mouth ulcer.
• Blood : Anemia.
• Central Nervous System : Headache, change in taste, dizziness, and sleeplessness.
• Musculoskeletal : Muscle pain, joint pain.
• Infections : Upper respiratory tract infection, nose inflammation.
• Respiratory : Difficulty in breathing.
• Metabolic : Decreased appetite.
• Eye : Increased tears.
Avoid excess dosage.
Store vials in a refrigerator at 2°C to 8°C.
Subscribe to our Free Newsletters!